Scientists from The Universities of Manchester and Auckland have discovered widespread differences in metal levels in the brains of patients with Huntington's disease, a type of dementia, compared to a control group with ...
Oct 17, 2023
0
76
Scientists in America have developed a nasal spray that can remove proteins in the brain associated with Alzheimer's disease—at least, in mice.
Jul 26, 2024
0
31
New Alzheimer's research from UVA Health suggests that enhanced light sensitivity may contribute to "sundowning"—the worsening of the disease's symptoms late in the day—and spur sleep disruptions thought to contribute ...
Jul 27, 2023
0
22
New research appearing in the journal Nature Biotechnology answers important questions about the viability of treatments that seek to replace diseased and aged cells in the central nervous system with healthy ones. Its findings ...
Jul 17, 2023
0
14
A new compound developed at the University of Illinois Chicago potentially could offer an alternative to injections for the millions of people who suffer from an eye condition that causes blindness.
Oct 3, 2023
0
31
A research group at the University of Helsinki and its partners have found a promising drug candidate for the treatment of amyotrophic lateral sclerosis (ALS). Cerebral dopamine neurotrophic factor CDNF prolongs the lifespan ...
Sep 22, 2023
0
23
The brain contains many cell types, from the prominent neurons to the lesser-known microglia. The latter are integral to the brain's immune system and play a crucial role as the brain's cleanup crew. A recent study conducted ...
Jul 26, 2024
0
92
Researchers at Karolinska Institutet have made exciting discoveries about Alzheimer's disease, a common form of dementia affecting millions of people around the world. In a study published in Alzheimer's & Dementia, they ...
Feb 16, 2024
0
3
New research published in the New England Journal of Medicine indicates that stem cell gene therapy may offer a promising, curative treatment for the painful, inherited blood disorder sickle cell disease (SCD).
Aug 30, 2023
0
41
Peresolimab, a humanized immunoglobulin G1 monoclonal antibody designed to stimulate the endogenous programmed cell death protein 1 (PD-1) inhibitory pathway, is efficacious for patients with rheumatoid arthritis, according ...
May 18, 2023
0
18
